Pharma company gets $2.7M grant to continue "positive" Alzheimer"s treatment trials

Rhythm Pharma shares jumped on Wednesday after the company announced positive results from two of its late-stage obesity clinical trials......»»

Sol-Gel Technologies Ltd. shares soared 9.5% in premarket trade Monday, after the company said that two late-stage trials of a tr.....»»

Shares of Biogen Inc. soared 12% toward a five-month high in premarket trade Friday, after the biotechnology company and Tokyo-based Eisai Co. Ltd. announced positive results from a.....»»

AP/Alastair Grant Biotech startup Alector is getting ready to put its first batch of neurodegenerative drugs into humans after raising an additional $133 million.  Alector is developing treatments that harness the body's immune system to tackle.....»»

The company posted positive results from two late-stage studies of its experimental treatment for a highly contagious skin disease that afflicts primarily children......»»

Ultragenyx Pharma shares made a handy gain to close out the week after the company announced positive results from its midstage trial for the treatment of glycogen storage disease type Ia......»»

Shares of BioLine RX Ltd. rocketed 60% toward a 2-year high in very active trading Tuesday, enough to pace all of the premarket gainers, after the biopharmaceutical company announced positive results from a Phase 3 trial of its treatment for multi.....»»

A Florida-based biotechnology company developing a portfolio of psychoactive medications for the treatment of mental health disorders has awarded a $1.5 million grant to researchers at Miami University......»»

The company is working on several Covid-related trials, including for a number of vaccines.....»»

The company is currently applying in the U.S. for the right to make a generic version of a Pfizer treatment for breast cancer......»»

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Shares of Bluebird Bio Inc. slid 34% in premarket trade Tuesday, after the biotech said it is temporarily suspending Phase 1/2 and Phase 3 trials of .....»»

Shares of Heat Biologics Inc. more than doubled in very active trading Tuesday, after the biopharmaceutical company focused on modulating the immune system reported "positive" in.....»»

Shares of UniQure gained 7.2% in trading on Monday after the company said an independent data safety monitoring board said there were no safety concerns in a Phase 2/3 clinical trial for its experimental Huntington's disease treatment. The boar.....»»

Shares of Cassava Sciences Inc. more than doubled toward a near 10-year high in very active trading Tuesday, after the company focused on neurodegenerative disease treatments announced upbeat results from a stu.....»»

More than 113 million shares of the company traded on Tuesday. By comparison, 295,200 shares changed hands on Friday......»»

Shares of Biogen Inc. gained 5.6% in trading on Monday after another drugmaker shared positive clinical data about an experimental Alzheimer's disease treatment that is similar to a Biogen therapy under review by the Food and Drug A.....»»

Shares of Veru Inc. soared 51.4% toward a seven-year high on massive volume, after the biopharmaceutical company announced positive results from a Phase 2 study of its treatment.....»»

Shares of Cassava Sciences Inc. tumbled 73.2% in trading on Friday after the company said its investigational Alzheimer's disease treatment failed a mid-.....»»

The Louisville-based mental health care and addiction treatment provider will use the $4 million to continue a program that it's piloted for two years......»»